Almac Group, an established CDMO, provides a unique range of integrated drug development services to the pharmaceutical and biotech industry. Our quality, innovation and efficiency are why over 600 companies worldwide trust Almac to support their clinical trials and ultimately commercialisation. Our solutions are tailored to meet client needs and range from API manufacture, analytical services, formulation development, clinical trial supply manufacture and packaging, supply chain management through to product launch and commercial-scale manufacture and packaging. As an established provider of drug substance and drug product manufacture, and packaging services in support of clinical trials, and by offering these as an integrated CMC solution, our client partners are assured of scientific continuity from a dedicated project team, resulting in savings in both time and cost. Whether your requirements are for First in Human supplies or later phase development, manufacture or registration batches, Almac has access to a wide range of technologies for both potent and non-potent, solid oral dose products. Integrated CMC operations allow for optimal communication and knowledge transfer on projects. Our clients leverage this combined service offering, exploiting the Almac advantage of a single partner approach.